(Q51065281)

28 March 2018

title

Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality. (English)

1 reference

28 March 2018

0 references

6

Patrick W Serruys

1 reference

28 March 2018

2

Johan Denollet

1 reference

28 March 2018

Susanne S Pedersen

1

1 reference

28 March 2018

Andrew T L Ong

3

1 reference

28 March 2018

Karel Sonnenschein

4

1 reference

28 March 2018

Ruud A M Erdman

5

1 reference

28 March 2018

Ron T van Domburg

7

1 reference

28 March 2018

publication date

1 February 2007

1 reference

28 March 2018

European Journal of Cardiovascular Prevention and Rehabilitation

published in

1 reference

28 March 2018

volume

14

1 reference

28 March 2018

issue

1

1 reference

28 March 2018

page(s)

135-140

1 reference

28 March 2018

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

cites work

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Paradigm shifts in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Screening for psychosocial risk factors in patients with coronary heart disease-recommendations for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Depression as a risk factor for mortality after coronary artery bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Vital exhaustion predicts new cardiac events after successful coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Personality as independent predictor of long-term mortality in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Inadequate response to treatment in coronary heart disease : adverse effects of type D personality and younger age on 5-year prognosis and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Type D personality, cardiac events, and impaired quality of life: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

The distressed (type D) personality is independently associated with impaired health status and increased depressive symptoms in chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Type D personality is associated with increased anxiety and depressive symptoms in patients with an implantable cardioverter defibrillator and their partners.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Social inhibition modulates the effect of negative emotions on cardiac prognosis following percutaneous coronary intervention in the drug-eluting stent era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus-eluting stent implantation: a Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

DS14: standard assessment of negative affectivity, social inhibition, and Type D personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Increased vital exhaustion among type-D patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Impact of preprocedural white blood cell count on long term mortality after percutaneous coronary intervention: insights from the EPIC, EPILOG, and EPISTENT trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Inflammation and restenosis after percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Cytokines and immune activation in systolic heart failure: the role of Type D personality

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary21When citing this document, the American College of Cardiology and the American Heart Association would appreciate the following cita

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FHJR.0B013E328045C282

10.1097/HJR.0B013E328045C282

21 January 2018

Identifiers

DOI

1 reference

28 March 2018

1 reference

28 March 2018